尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Anders Lundberg, Président du Conseil. Insider active across 1 company, notably Prostatype Genomics AB. Aggregated, 2 disclosures have been logged. Activity tracked since 3 October 2025. The latest transaction was filed on 12 August 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Anders Lundberg is the Chairman of the Board of Prostatype Genomics AB. As Chairman, he oversees the activities of the board and ensures the good governance of the company. Anders plays a key role in defining strategic directions and supporting the management of Prostatype Genomics AB.